Krystal Biotech buy Bank of America Co.
Start price
22.01.26
/
50%
€246.10
Target price
22.01.27
€272.02
Performance (%)
19.38%
Price
19.08.26
€293.80
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ currently has a performance of 19.38%. This prediction currently runs until 22.01.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 1.802% | 1.802% |
| iShares Core DAX® | -1,06 % | 5,01 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % |
| iShares S&P 500 | -1,78 % | 1,39 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Bank of America Corporation from $288.00 to $318.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€297.90
14.07.26
14.07.26
€347.61
14.07.27
14.07.27
-1.38%
19.08.26
19.08.26
Krystal Biotech
Start price
Target price
Perf. (%)
€159.10
17.10.25
17.10.25
€217.90
17.10.26
17.10.26
84.66%
19.08.26
19.08.26
Krystal Biotech
Start price
Target price
Perf. (%)
€129.30
22.07.25
22.07.25
€164.24
22.07.26
22.07.26
125.52%
23.07.26
23.07.26